Search Results - "Drug Administration Schedule"

Long Dosing Intervals of Parenteral Antiosteoporosis Medications and the Decrease in Societal Fracture Risk: An 11-Year Nationwide Population-Based Cohort Study.

Authors: Fu SH Yen HK Yang RS et al.

Source: Mayo Clinic proceedings [Mayo Clin Proc] 2025 Jan; Vol. 100 (1), pp. 68-79. Date of Electronic Publication: 2024 Dec 12.

Publication Type: Journal Article

Journal Info: Publisher: [Oxford, England] Country of Publication: England NLM ID: 0405543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-5546 (Electronic) Linking ISSN: 00256196 NLM ISO Abbreviation: Mayo Clin Proc Subsets: MEDLINE

MeSH Terms: Osteoporosis*/drug therapy , Osteoporosis*/epidemiology , Bone Density Conservation Agents*/administration & dosage , Bone Density Conservation Agents*/therapeutic use , Drug Administration Schedule* , Medication Adherence*/statistics & numerical data , Osteoporotic Fractures*/prevention & control , Osteoporotic Fractures*/epidemiology, Humans ; Female ; Male ; Middle Aged ; Aged ; Taiwan/epidemiology ; Cohort Studies ; Administration, Oral

Timing of anticoagulation for patients with atrial fibrillation after acute ischemic stroke: Systematic review and meta-analysis.

Authors: Al-Janabi OM Odeh A Gajjar A et al.

Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2025 Jan; Vol. 34 (1), pp. 108159. Date of Electronic Publication: 2024 Nov 29.

Publication Type: Systematic Review; Journal Article; Meta-Analysis

Journal Info: Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8511 (Electronic) Linking ISSN: 10523057 NLM ISO Abbreviation: J Stroke Cerebrovasc Dis Subsets: MEDLINE

MeSH Terms: Atrial Fibrillation*/drug therapy , Atrial Fibrillation*/diagnosis , Atrial Fibrillation*/mortality , Atrial Fibrillation*/complications , Anticoagulants*/adverse effects , Anticoagulants*/administration & dosage , Ischemic Stroke*/mortality , Ischemic Stroke*/diagnosis , Ischemic Stroke*/prevention & control , Ischemic Stroke*/drug therapy , Time-to-Treatment* , Recurrence* , Drug Administration Schedule*, Humans ; Time Factors ; Treatment Outcome ; Risk Factors ; Aged ; Risk Assessment ; Male ; Female ; Secondary Prevention ; Middle Aged ; Aged, 80 and over ; Intracranial Hemorrhages/chemically induced ; Intracranial Hemorrhages/mortality

Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial.

Authors: Hakeem A Shah JA Kumar R et al.

Corporate Authors: Hakeem A Shah JA Kumar R et al.

Source: Journal of the American College of Cardiology [J Am Coll Cardiol] 2025 Dec 09; Vol. 86 (23), pp. 2330-2345. Date of Electronic Publication: 2025 Aug 30.

Publication Type: Journal Article; Randomized Controlled Trial; Comparative Study

Journal Info: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE

MeSH Terms: Ticagrelor*/administration & dosage , Ticagrelor*/adverse effects , Clopidogrel*/administration & dosage , Clopidogrel*/adverse effects , Percutaneous Coronary Intervention*/adverse effects , Platelet Aggregation Inhibitors*/administration & dosage , ST Elevation Myocardial Infarction*/surgery, Humans ; Male ; Female ; Middle Aged ; Double-Blind Method ; Aged ; Drug Administration Schedule

Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study.

Authors: Noureddin M Harrison SA Loomba R et al.

Source: Lancet (London, England) [Lancet] 2025 Dec 06; Vol. 406 (10520), pp. 2644-2655. Date of Electronic Publication: 2025 Nov 11.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

MeSH Terms: Liver Cirrhosis*/drug therapy , Liver Cirrhosis*/etiology , Liver Cirrhosis*/pathology , Pyridines*/administration & dosage , Pyridines*/adverse effects , Pyridines*/therapeutic use , Fatty Liver*/drug therapy, Humans ; Double-Blind Method ; Male ; Female ; Middle Aged ; Adult ; Treatment Outcome ; Aged ; Drug Administration Schedule ; Non-alcoholic Fatty Liver Disease/drug therapy

Evening administration of long-acting muscarinic antagonists in COPD - a randomized controlled trial.

Authors: Sivapalan P Rømer V Jordan A et al.

Source: BMC pulmonary medicine [BMC Pulm Med] 2025 Dec 03; Vol. 25 (1), pp. 552. Date of Electronic Publication: 2025 Dec 03.

Publication Type: Journal Article; Randomized Controlled Trial; Pragmatic Clinical Trial

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE

MeSH Terms: Pulmonary Disease, Chronic Obstructive*/drug therapy , Pulmonary Disease, Chronic Obstructive*/mortality , Muscarinic Antagonists*/administration & dosage, Humans ; Male ; Female ; Aged ; Middle Aged ; Denmark ; Hospitalization/statistics & numerical data ; Drug Administration Schedule ; Disease Progression ; Adrenergic beta-2 Receptor Agonists/therapeutic use

Thrice-weekly post-haemodialysis ceftazidime can achieve adequate pre-dialysis concentrations and clinical cure in patients with melioidosis.

Authors: Smith S Reilly CW Stewart J et al.

Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2025 Dec 02; Vol. 80 (12), pp. 3386-3390.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

MeSH Terms: Melioidosis*/drug therapy , Ceftazidime*/administration & dosage , Ceftazidime*/therapeutic use , Ceftazidime*/pharmacokinetics , Anti-Bacterial Agents*/administration & dosage , Anti-Bacterial Agents*/therapeutic use , Burkholderia pseudomallei*/drug effects , Renal Dialysis*, Humans ; Male ; Female ; Middle Aged ; Aged ; Microbial Sensitivity Tests ; Retrospective Studies ; Adult ; Treatment Outcome ; Drug Administration Schedule ; Aged, 80 and over

Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 study.

Authors: Eslinger C Walden D Krivonos A et al.

Source: Cancer [Cancer] 2025 Dec 01; Vol. 131 (23), pp. e70184.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

MeSH Terms: Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/pharmacokinetics , Gastrointestinal Neoplasms*/drug therapy , Gastrointestinal Neoplasms*/pathology , Gastrointestinal Neoplasms*/genetics , Indoles*/administration & dosage , Indoles*/adverse effects , Indoles*/pharmacokinetics, Humans ; Female ; Middle Aged ; Male ; Aged ; Irinotecan/administration & dosage ; Irinotecan/adverse effects ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Maximum Tolerated Dose ; Liposomes ; Adult ; Drug Administration Schedule ; Poly(ADP-ribose) Polymerase Inhibitors/administration & dosage ; Neoplasm Metastasis ; Treatment Outcome

Personalizing denosumab therapy in postmenopausal Indian women with osteoporosis: predictive role of bone turnover markers and body mass index in determining dosing interval.

Authors: Jha V Bhadada SK Pal R et al.

Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2025 Dec; Vol. 36 (12), pp. 2531-2539. Date of Electronic Publication: 2025 Sep 29.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2965 (Electronic) Linking ISSN: 0937941X NLM ISO Abbreviation: Osteoporos Int Subsets: MEDLINE

MeSH Terms: Denosumab*/administration & dosage , Denosumab*/adverse effects , Denosumab*/therapeutic use , Osteoporosis, Postmenopausal*/drug therapy , Osteoporosis, Postmenopausal*/physiopathology , Osteoporosis, Postmenopausal*/blood , Bone Density Conservation Agents*/administration & dosage , Bone Density Conservation Agents*/adverse effects , Bone Density Conservation Agents*/therapeutic use , Body Mass Index* , Bone Remodeling*/drug effects , Bone Remodeling*/physiology, Humans ; Female ; Middle Aged ; Aged ; Prospective Studies ; Biomarkers/blood ; Drug Administration Schedule ; Precision Medicine/methods ; Osteoporotic Fractures/prevention & control ; Osteoporotic Fractures/physiopathology ; Peptides/blood ; Bone Density/drug effects ; Collagen Type I/blood

Timing of human chorionic gonadotropin administration affects conception rates after embryo transfer in crossbred beef heifers.

Authors: Hazano K Goto A Haneda S et al.

Source: The Journal of veterinary medical science [J Vet Med Sci] 2025 Dec 01; Vol. 87 (12), pp. 1426-1431. Date of Electronic Publication: 2025 Oct 09.

Publication Type: Journal Article; Randomized Controlled Trial, Veterinary

Journal Info: Publisher: Japanese Society Of Veterinary Science Country of Publication: Japan NLM ID: 9105360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1347-7439 (Electronic) Linking ISSN: 09167250 NLM ISO Abbreviation: J Vet Med Sci Subsets: MEDLINE

MeSH Terms: Chorionic Gonadotropin*/administration & dosage , Chorionic Gonadotropin*/pharmacology , Embryo Transfer*/veterinary , Fertilization*/drug effects, Animals ; Cattle/physiology ; Female ; Pregnancy ; Time Factors ; Drug Administration Schedule ; Pregnancy Rate

Twice versus once daily application of 0.01% atropine for myopia control in children: a randomised controlled trial.

Authors: He M Zhang Z Tong L et al.

Source: Eye (London, England) [Eye (Lond)] 2025 Dec; Vol. 39 (17), pp. 3105-3112. Date of Electronic Publication: 2025 Oct 01.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE

MeSH Terms: Atropine*/administration & dosage , Mydriatics*/administration & dosage , Myopia*/drug therapy , Myopia*/physiopathology , Myopia, Degenerative*/physiopathology , Myopia, Degenerative*/drug therapy, Humans ; Child ; Female ; Male ; Adolescent ; Ophthalmic Solutions/administration & dosage ; Visual Acuity/physiology ; Axial Length, Eye/drug effects ; Refraction, Ocular/physiology ; Refraction, Ocular/drug effects ; Disease Progression ; Drug Administration Schedule ; Treatment Outcome

Clinical factors influencing the systolic blood pressure benefits of once-weekly semaglutide in patients with type 2 diabetes.

Authors: Ruiz-Sánchez JG Sierra Poyatos RM Luiza Luca B et al.

Source: Medicina clinica [Med Clin (Barc)] 2025 Dec; Vol. 165 (6), pp. 107179. Date of Electronic Publication: 2025 Sep 26.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8989 (Electronic) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

MeSH Terms: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/physiopathology , Glucagon-Like Peptides*/administration & dosage , Glucagon-Like Peptides*/therapeutic use , Blood Pressure*/drug effects , Hypertension*/drug therapy , Hypertension*/complications , Hypertension*/etiology , Hypoglycemic Agents*/administration & dosage , Hypoglycemic Agents*/therapeutic use, Humans ; Female ; Middle Aged ; Male ; Aged ; Drug Administration Schedule ; Treatment Outcome ; Glucagon-Like Peptide 1

Pharmacokinetics, Safety, and Tolerability of Different Maintenance Dose Regimens of Mosnodenvir (JNJ-1802) in Healthy Adult Participants.

Authors: Kakuda TN Harasym N Buelens A et al.

Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2025 Dec; Vol. 14 (12), pp. 960-970. Date of Electronic Publication: 2025 Jul 15.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

MeSH Terms: Antiviral Agents*/pharmacokinetics , Antiviral Agents*/administration & dosage , Antiviral Agents*/adverse effects, Humans ; Adult ; Male ; Female ; Young Adult ; Healthy Volunteers ; Middle Aged ; Drug Administration Schedule ; Dose-Response Relationship, Drug ; Half-Life ; Area Under Curve ; Adolescent ; Hydrocarbons, Halogenated ; Indoles

Timing of RAS blocker administration and long-term cardiovascular outcomes in STEMI patients.

Transliterated Title: Zeitpunkt der RAS-Blocker-Verabreichung und langfristige kardiovaskuläre Ergebnisse bei STEMI-Patienten.

Authors: Çetin T Karataş MB Eren S et al.

Source: Herz [Herz] 2025 Dec; Vol. 50 (6), pp. 460-468. Date of Electronic Publication: 2025 Jun 16.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Urban Und Vogel Country of Publication: Germany NLM ID: 7801231 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1615-6692 (Electronic) Linking ISSN: 03409937 NLM ISO Abbreviation: Herz Subsets: MEDLINE

MeSH Terms: ST Elevation Myocardial Infarction*/mortality , ST Elevation Myocardial Infarction*/drug therapy , Angiotensin-Converting Enzyme Inhibitors*/administration & dosage , Angiotensin Receptor Antagonists*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Treatment Outcome ; Percutaneous Coronary Intervention ; Drug Administration Schedule ; Renin-Angiotensin System/drug effects

Outcome trends in preterm infants with incomplete antenatal corticosteroid cycles: Is 6 h enough?

Authors: Kraft K Heßler N Rody A

Source: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2025 Dec; Vol. 315, pp. 114732. Date of Electronic Publication: 2025 Sep 22.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 0375672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7654 (Electronic) Linking ISSN: 03012115 NLM ISO Abbreviation: Eur J Obstet Gynecol Reprod Biol Subsets: MEDLINE

MeSH Terms: Infant, Premature* , Adrenal Cortex Hormones*/administration & dosage , Infant, Premature, Diseases*/prevention & control , Infant, Premature, Diseases*/epidemiology, Humans ; Female ; Infant, Newborn ; Retrospective Studies ; Pregnancy ; Bronchopulmonary Dysplasia/epidemiology ; Bronchopulmonary Dysplasia/prevention & control ; Gestational Age ; Enterocolitis, Necrotizing/epidemiology ; Male ; Time Factors ; Retinopathy of Prematurity/epidemiology ; Respiratory Distress Syndrome, Newborn ; Drug Administration Schedule

Comparison of the efficacy and safety of five-day methotrexate versus pulse actinomycin D for low-risk gestational trophoblastic neoplasia: a single-center historical cohort study ^☆ .

Authors: Katayama E Usui H Nakamura N et al.

Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2025 Dec; Vol. 35 (12), pp. 102657. Date of Electronic Publication: 2025 Sep 10.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

MeSH Terms: Dactinomycin*/administration & dosage , Dactinomycin*/adverse effects , Gestational Trophoblastic Disease*/drug therapy , Gestational Trophoblastic Disease*/pathology , Methotrexate*/administration & dosage , Methotrexate*/adverse effects , Antimetabolites, Antineoplastic*/administration & dosage , Antimetabolites, Antineoplastic*/adverse effects , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/adverse effects, Humans ; Female ; Pregnancy ; Adult ; Retrospective Studies ; Middle Aged ; Cohort Studies ; Drug Administration Schedule ; Young Adult

Efficacy and safety of Efsubaglutide Alfa in "overrun" patients in the SUPER2 trial: A post-hoc analysis for comprehensive evaluation.

Authors: Jia W Jiang F Xu Y et al.

Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2025 Dec; Vol. 27 (12), pp. 7123-7132. Date of Electronic Publication: 2025 Sep 22.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

MeSH Terms: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/blood , Hypoglycemic Agents*/administration & dosage , Hypoglycemic Agents*/adverse effects , Hypoglycemic Agents*/therapeutic use , Glucagon-Like Peptide-1 Receptor Agonists*, Humans ; Male ; Female ; Middle Aged ; Double-Blind Method ; Glycated Hemoglobin/analysis ; Glycated Hemoglobin/metabolism ; Metformin/therapeutic use ; Metformin/administration & dosage ; Blood Glucose/drug effects ; Blood Glucose/metabolism ; Aged ; Treatment Outcome ; Drug Therapy, Combination ; Adult ; Drug Administration Schedule

The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans-a histomorphometry centered scoping review.

Authors: Thomsen LK van Dijk Christiansen P Andreasen CM et al.

Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2025 Dec; Vol. 36 (12), pp. 2411-2435. Date of Electronic Publication: 2025 Sep 09.

Publication Type: Journal Article; Scoping Review; Review

Journal Info: Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2965 (Electronic) Linking ISSN: 0937941X NLM ISO Abbreviation: Osteoporos Int Subsets: MEDLINE

MeSH Terms: Bone Remodeling*/drug effects , Parathyroid Hormone*/pharmacology , Parathyroid Hormone*/administration & dosage , Parathyroid Hormone*/therapeutic use , Osteoporosis*/drug therapy , Osteoporosis*/physiopathology , Osteoporosis*/pathology, Humans ; Osteoblasts/drug effects ; Osteoclasts/drug effects ; Osteoclasts/physiology ; Hypoparathyroidism/drug therapy ; Hypoparathyroidism/physiopathology ; Osteogenesis/drug effects ; Hormone Replacement Therapy/methods ; Drug Administration Schedule ; Biomarkers/metabolism

Long-term adherence to flecainide as a rhythm control therapy in recurrent atrial fibrillation - a retrospective cohort study.

Authors: Siotis A Johansson S Graff C et al.

Source: Scandinavian cardiovascular journal : SCJ [Scand Cardiovasc J] 2025 Dec; Vol. 59 (1), pp. 2525110. Date of Electronic Publication: 2025 Jun 26.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-2006 (Electronic) Linking ISSN: 14017431 NLM ISO Abbreviation: Scand Cardiovasc J Subsets: MEDLINE

MeSH Terms: Flecainide*/adverse effects , Flecainide*/administration & dosage , Atrial Fibrillation*/drug therapy , Atrial Fibrillation*/physiopathology , Atrial Fibrillation*/diagnosis , Anti-Arrhythmia Agents*/adverse effects , Anti-Arrhythmia Agents*/administration & dosage , Heart Rate*/drug effects , Medication Adherence*, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Time Factors ; Recurrence ; Treatment Outcome ; Aged ; Electrocardiography ; Risk Factors ; Action Potentials ; Drug Administration Schedule

Bimekizumab as-needed dosing in patients with psoriasis: a case series.

Authors: Abbad-Jaime De Aragón C Berna-Rico E Jaén P et al.

Source: The Journal of dermatological treatment [J Dermatolog Treat] 2025 Dec; Vol. 36 (1), pp. 2492197. Date of Electronic Publication: 2025 Apr 21.

Publication Type: Journal Article

Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

MeSH Terms: Psoriasis*/drug therapy , Psoriasis*/diagnosis , Psoriasis*/immunology , Dermatologic Agents*/administration & dosage , Dermatologic Agents*/adverse effects , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/adverse effects, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Adult ; Treatment Outcome ; Off-Label Use ; Severity of Illness Index ; Aged ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Spain

A Single- and Multiple-Dose Study to Characterize the Pharmacokinetics and Safety of Dotinurad in Healthy Chinese Adults.

Authors: Liu Y Chen Q Sun H et al.

Source: Clinical drug investigation [Clin Drug Investig] 2025 Dec; Vol. 45 (12), pp. 957-966. Date of Electronic Publication: 2025 Oct 19.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE

MeSH Terms: Triazoles*/pharmacokinetics , Triazoles*/adverse effects , Triazoles*/administration & dosage , Uricosuric Agents*/pharmacokinetics , Uricosuric Agents*/adverse effects , Uricosuric Agents*/administration & dosage, Adolescent ; Adult ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; Administration, Oral ; China ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Healthy Volunteers ; East Asian People ; Benzothiazoles